{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:19:25Z","timestamp":1785237565030,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver metastasis is a recalcitrant disease that usually leads to death of the patient. The present study established a unique patient-derived orthotopic xenograft (PDOX) nude mouse model of a highly aggressive liver metastasis of colon cancer. The aim of the present study was to demonstrate proof-of-concept that candidate drug combinations could significantly inhibit growth and re-metastasis of this recalcitrant tumor. The patient\u2019s liver metastasis was initially established subcutaneously in nude mice and the subcutaneous tumor tissue was then orthotopically implanted in the liver of nude mice to establish a PDOX model. Two studies were performed to test different drugs or drug combination, indicating that 5-fluorouracil (5-FU)\u2009+\u2009irinotecan (IRI)\u2009+\u2009bevacizumab (BEV) and regorafenib (REG)\u2009+\u2009selumetinib (SEL) had significantly inhibited liver metastasis growth (<jats:italic>p<\/jats:italic>\u2009=\u20090.013 and <jats:italic>p<\/jats:italic>\u2009=\u20090.035, respectively), and prevented liver satellite metastasis. This study is proof of concept that a PDOX model of highly aggressive colon-cancer metastasis can identify effective drug combinations and that the model has future clinical potential.<\/jats:p>","DOI":"10.1038\/s41598-020-76708-9","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T11:05:54Z","timestamp":1605697554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations"],"prefix":"10.1038","volume":"10","author":[{"given":"Zhiying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Kiyuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintawat","family":"Wangsiricharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Razmjooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masuyo","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant P.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree Ram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"76708_CR1","volume-title":"Current Surgical Therapy","author":"JL Cameron","year":"2013","unstructured":"Cameron, J. L. & Cameron, A. M. Current Surgical Therapy (Elsevier, Amsterdam, 2013)."},{"key":"76708_CR2","unstructured":"National Comprehensive Cancer Network. Colon Cancer (Version 4.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf (2020)."},{"key":"76708_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1634\/theoncologist.2008-0142","volume":"13","author":"SR Alberts","year":"2008","unstructured":"Alberts, S. R. & Wagman, L. D. Chemotherapy for colorectal cancer liver metastases. Oncologist 13, 1063\u20131073 (2008).","journal-title":"Oncologist"},{"key":"76708_CR4","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9, T. et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350, 2343\u20132351 (2004).","journal-title":"N. Engl. J. Med."},{"key":"76708_CR5","doi-asserted-by":"publisher","first-page":"175883591878799","DOI":"10.1177\/1758835918787993","volume":"10","author":"P Pfeiffer","year":"2018","unstructured":"Pfeiffer, P., Gruenberger, T. & Glynne-Jones, R. Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?. Ther. Adv. Med. Oncol. 10, 1758835918787993 (2018).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"76708_CR6","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1200\/JCO.2011.41.1140","volume":"30","author":"HK Sanoff","year":"2012","unstructured":"Sanoff, H. K. et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. JCO 30, 2624\u20132634 (2012).","journal-title":"JCO"},{"key":"76708_CR7","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1158\/1078-0432.CCR-17-0898","volume":"23","author":"A Barone","year":"2017","unstructured":"Barone, A. et al. FDA approval summary: trabectedin for unresectable or metastatic liposarcoma or leiomyosarcoma following an anthracycline-containing regimen. Clin. Cancer Res. 23, 7448\u20137453 (2017).","journal-title":"Clin. Cancer Res."},{"key":"76708_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jjco\/hyx144","volume":"48","author":"T Seto","year":"2018","unstructured":"Seto, T. et al. Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer. Jpn. J. Clin. Oncol. 48, 31\u201342 (2018).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"76708_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/lap.2013.0418","volume":"24","author":"Y Hiroshima","year":"2014","unstructured":"Hiroshima, Y. et al. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system. J. Laparoendosc. Adv. Surg. Tech. A 24, 241\u2013247 (2014).","journal-title":"J. Laparoendosc. Adv. Surg. Tech. A"},{"key":"76708_CR10","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.88.20.9345","volume":"88","author":"XY Fu","year":"1991","unstructured":"Fu, X. Y., Besterman, J. M., Monosov, A. & Hoffman, R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. PNAS 88, 9345\u20139349 (1991).","journal-title":"PNAS"},{"key":"76708_CR11","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ijc.2910510621","volume":"51","author":"X Wang","year":"1992","unstructured":"Wang, X., Fu, X. & Hoffman, R. M. A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice. Int. J. Cancer 51, 992\u2013995 (1992).","journal-title":"Int. J. Cancer"},{"key":"76708_CR12","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1073\/pnas.89.12.5645","volume":"89","author":"X Fu","year":"1992","unstructured":"Fu, X., Guadagni, F. & Hoffman, R. M. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc. Natl. Acad. Sci. 89, 5645\u20135649 (1992).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"76708_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.canlet.2018.06.016","volume":"432","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi, K. et al. Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer. Cancer Lett. 432, 251\u2013259 (2018).","journal-title":"Cancer Lett."},{"key":"76708_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ijc.2910530414","volume":"53","author":"T Furukawa","year":"1993","unstructured":"Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M. & Hoffman, R. M. Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int. J. Cancer 53, 608\u2013612 (1993).","journal-title":"Int. J. Cancer"},{"key":"76708_CR15","first-page":"901","volume":"13","author":"X Fu","year":"1993","unstructured":"Fu, X., Le, P. & Hoffman, R. M. A metastatic orthotopic-transplant nude-mouse model of human patient breast cancer. Anticancer Res. 13, 901\u2013904 (1993).","journal-title":"Anticancer Res."},{"key":"76708_CR16","first-page":"283","volume":"13","author":"X Fu","year":"1993","unstructured":"Fu, X. & Hoffman, R. M. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res. 13, 283\u2013286 (1993).","journal-title":"Anticancer Res."},{"key":"76708_CR17","doi-asserted-by":"publisher","first-page":"e0117417","DOI":"10.1371\/journal.pone.0117417","volume":"10","author":"Y Hiroshima","year":"2015","unstructured":"Hiroshima, Y. et al. Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. PLoS ONE 10, e0117417 (2015).","journal-title":"PLoS ONE"},{"key":"76708_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jcb.240560104","volume":"56","author":"P Astoul","year":"1994","unstructured":"Astoul, P., Colt, H. G., Wang, X., Boutain, C. & Hoffman, R. M. \u201cPatient-Like\u201d nude mouse metastatic model of advanced human pleural cancer. J. Cell. Biochem. 56, 9\u201315 (1994).","journal-title":"J. Cell. Biochem."},{"key":"76708_CR19","doi-asserted-by":"publisher","first-page":"e0160882","DOI":"10.1371\/journal.pone.0160882","volume":"11","author":"M Yamamoto","year":"2016","unstructured":"Yamamoto, M. et al. Efficacy of tumor-targeting salmonella A1-R on a melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. PLoS ONE 11, e0160882 (2016).","journal-title":"PLoS ONE"},{"key":"76708_CR20","doi-asserted-by":"publisher","first-page":"33046","DOI":"10.18632\/oncotarget.8848","volume":"7","author":"T Kiyuna","year":"2016","unstructured":"Kiyuna, T. et al. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model. Oncotarget 7, 33046\u201333054 (2016).","journal-title":"Oncotarget"},{"key":"76708_CR21","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1002\/jcb.26792","volume":"119","author":"K Igarashi","year":"2018","unstructured":"Igarashi, K. et al. Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy. J. Cell. Biochem. 119, 6598\u20136603 (2018).","journal-title":"J. Cell. Biochem."},{"key":"76708_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.phrs.2019.02.021","volume":"142","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma. Pharmacol. Res. 142, 169\u2013175 (2019).","journal-title":"Pharmacol. Res."},{"key":"76708_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/15384101.2016.1252885","volume":"16","author":"K Igarashi","year":"2017","unstructured":"Igarashi, K. et al. Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model. Cell Cycle 16, 91\u201394 (2017).","journal-title":"Cell Cycle"},{"key":"76708_CR24","doi-asserted-by":"publisher","first-page":"71696","DOI":"10.18632\/oncotarget.12322","volume":"7","author":"Y Hiroshima","year":"2016","unstructured":"Hiroshima, Y. et al. Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy. Oncotarget 7, 71696\u201371702 (2016).","journal-title":"Oncotarget"},{"key":"76708_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrc3972","volume":"15","author":"RM Hoffman","year":"2015","unstructured":"Hoffman, R. M. Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts. Nat. Rev. Cancer 15, 451\u2013452 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"76708_CR26","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.0705226104","volume":"104","author":"V Damiano","year":"2007","unstructured":"Damiano, V. et al. TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. Proc. Natl. Acad. Sci. USA 104, 12468\u201312473 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76708_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s10637-010-9520-5","volume":"30","author":"ER Gardner","year":"2012","unstructured":"Gardner, E. R. et al. Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab. Invest New Drugs 30, 90\u201397 (2012).","journal-title":"Invest New Drugs"},{"key":"76708_CR28","doi-asserted-by":"publisher","first-page":"12346","DOI":"10.18632\/oncotarget.2641","volume":"5","author":"Y Hiroshima","year":"2014","unstructured":"Hiroshima, Y. et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models. Oncotarget 5, 12346\u201312357 (2014).","journal-title":"Oncotarget"},{"key":"76708_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","volume":"59","author":"SM Robinson","year":"2013","unstructured":"Robinson, S. M. et al. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. J. Hepatol. 59, 318\u2013326 (2013).","journal-title":"J. Hepatol."},{"key":"76708_CR30","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1158\/1078-0432.CCR-15-3112","volume":"22","author":"P Limani","year":"2016","unstructured":"Limani, P. et al. Antihypoxic potentiation of standard therapy for experimental colorectal liver metastasis through Myo-Inositol trispyrophosphate. Clin. Cancer Res. 22, 5887\u20135897 (2016).","journal-title":"Clin. Cancer Res."},{"key":"76708_CR31","first-page":"5463","volume":"37","author":"M Ikemura","year":"2017","unstructured":"Ikemura, M. & Hashida, T. Effect of hyperglycemia on antitumor activity and survival in tumor-bearing mice receiving oxaliplatin and fluorouracil. Anticancer Res. 37, 5463\u20135468 (2017).","journal-title":"Anticancer Res."},{"key":"76708_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3835(96)04477-1","volume":"110","author":"S Ohwada","year":"1996","unstructured":"Ohwada, S. et al. Interferon potentiates antiproliferative activity of CPT-11 against human colon cancer xenografts. Cancer Lett. 110, 149\u2013154 (1996).","journal-title":"Cancer Lett."},{"key":"76708_CR33","first-page":"3950","volume":"62","author":"M Motwani","year":"2002","unstructured":"Motwani, M., Sirotnak, F. M., She, Y., Commes, T. & Schwartz, G. K. Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells. Cancer Res. 62, 3950\u20133955 (2002).","journal-title":"Cancer Res."},{"key":"76708_CR34","first-page":"713","volume":"27","author":"Y Ji","year":"2007","unstructured":"Ji, Y. et al. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer. Anticancer Res. 27, 713\u2013718 (2007).","journal-title":"Anticancer Res."},{"key":"76708_CR35","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s12885-018-4703-0","volume":"18","author":"T Kiyuna","year":"2018","unstructured":"Kiyuna, T. et al. Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model. BMC Cancer 18, 840 (2018).","journal-title":"BMC Cancer"},{"key":"76708_CR36","doi-asserted-by":"publisher","first-page":"e0142612","DOI":"10.1371\/journal.pone.0142612","volume":"10","author":"E Daudigeos-Dubus","year":"2015","unstructured":"Daudigeos-Dubus, E. et al. Regorafenib: antitumor activity upon mono and combination therapy in preclinical pediatric malignancy models. PLoS ONE 10, e0142612 (2015).","journal-title":"PLoS ONE"},{"key":"76708_CR37","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","volume":"375","author":"E Dombi","year":"2016","unstructured":"Dombi, E. et al. Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas. N. Engl. J. Med. 375, 2550\u20132560 (2016).","journal-title":"N. Engl. J. Med."},{"key":"76708_CR38","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1158\/1078-0432.CCR-14-0902","volume":"20","author":"E Weisberg","year":"2014","unstructured":"Weisberg, E. et al. Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1R. Clin. Cancer Res. 20, 5483\u20135495 (2014).","journal-title":"Clin. Cancer Res."},{"key":"76708_CR39","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1073\/pnas.92.26.12085","volume":"92","author":"TH Kuo","year":"1995","unstructured":"Kuo, T. H. et al. Liver colonization competence governs colon cancer metastasis. Proc. Natl. Acad. Sci. USA 92, 12085\u201312089 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"76708_CR40","doi-asserted-by":"publisher","first-page":"11573","DOI":"10.1073\/pnas.94.21.11573","volume":"94","author":"T Chishima","year":"1997","unstructured":"Chishima, T. et al.\u00a0Governing step of metastasis visualized in vitro. PNAS USA\u00a094(21), 11573\u201311576 (1997).","journal-title":"PNAS USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76708-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:43:04Z","timestamp":1670370184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76708-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76708"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76708-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"27 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AntiCancer Inc. uses PDOX models for contract research. Z.Z., K.M., T.K. H.O., S.W. K.K. T.H, S.R, M.M., and R.M.H. are or were unsalaried associates of AntiCancer Inc. There are no other competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20105"}}